With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Morningside Campus Access Updates
Yellow Level from 7 a.m. to 7 p.m.: Open to all.
Orange Level from 7 p.m. to 7 a.m.: CUID holders and pre-authorized guests only; limited campus entry points.
Read more.
